Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-11-02

FDA Approved: LANOXIN — Supplemental Application (Covis Pharma US, Inc)

View source ↗

Summary

The FDA approved a supplemental application for LANOXIN (digoxin) submitted by Covis Pharma US, Inc. This approval covers the changes requested in the supplemen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LANOXIN (Digoxin)

Snippet

SUPPL AP for LANOXIN (DIGOXIN)